Harald Hampel is recognized as an influential leader in neuroscience, and will bring expertise in Alzheimer's disease to BMS.

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Discover how advanced Battery Management Systems (BMS) are enhancing electric vehicle efficiency and reliability by embedding ...

FRANKFURT, Nov 3 (Reuters) - Germany's BioNTech (22UAy.DE), opens new tab on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb (BMY.N), ...

The future of electric vehicles depends on battery packs that are safe, efficient, and easy to maintain. Wireless battery-management systems introduce a new way to cover all of these needs. What’s the ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

If you have kids, you’ve probably heard them blurt out “6-7” recently, with emphasis on the seven. Something like six-seven. Gen Alpha are randomly repeating the numbers and laughing at the inside ...

On the heels of the launch of an online direct-to-patient (DTP) program offering discounted Eliquis to certain U.S. patients, Bristol Myers Squibb is putting Sotyku at the center of its next DTP ...

Beecher Manufacturing Services acquired BMS Manufacturing Co. in Watkins Glen, New York. The acquisition will help Ward Apparatus, another Beecher company, increase fire truck production. The ...

BRISTOL, Tenn. (WJHL) — The MLB Speedway Classic will break the league’s record for regular-season single-game attendance, Bristol Motor Speedway (BMS) announced on Monday. In a news release, BMS ...

The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform patients in the state that the drug is likely to be less effective for them.

Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...